Automated immunoassay platforms for enhancing AAV analytics
Feb
7
2024
On demand

Automated immunoassay platforms for enhancing AAV analytics

Wednesday 08:00 PST / 11:00 EST / 16:00 GMT / 17:00 CET
Sponsor
Automated immunoassay platforms for enhancing AAV analytics

Adeno-associated viruses (AAVs) are the leaders in therapeutic gene delivery, distinguished by their remarkable capacity to efficiently infect a diverse range of cell types. Despite their successes, the industry still grapples with hurdles in producing and characterizing high-quality AAVs at a clinical scale with optimal efficiency. To achieve groundbreaking advancements in therapeutic interventions, advancements in AAV analytical tools are needed. The confluence of PROGEN’s 40-year legacy of reagent expertise with Bio-Techne's automated analytical solutions is a catalyst for redefining the future of gene therapy.

This webinar unveils the transformative power of automation in analytical AAV tools, introducing an era of unparalleled precision, reproducibility, and consistency.

  • Discover the significance of top-tier AAV antibody and protein reagents
  • Learn how to achieve fast and reproducible AAV titer using validated assay cartridges on Ella, an automated ELISA platform
  • See how Simple Western pairs molecular weight information with analytical grade immunoassay quantitation, providing an ideal tool for protein expression potency assays and other CQAs
  • Understand how a multi-attribute analytical tool such as Maurice can assist in unraveling CQAs from development through QC release
Lisa Mutz
Lisa Mutz
Product Manager at PROGEN

Lisa Mutz studied biology with a focus on molecular and cellular biology at the University in Heidelberg, Germany. In 2021, she finished her Master studies with the analysis of protein-protein interactions of the nuclearpore proteins Nup50/Nup53 by Bio-ID. Subsequently, after her thesis, Lisa started her role as a Product Manager at PROGEN in Heidelberg, Germany, where she initially started overseeing the non-AAV life science portfolio. In 2022, Lisa took over responsibility for the AAV portfolio, which represents PROGEN´s main focus area within the field of gene therapy.

Chris Heger
Chris Heger
Director of Applications Science, Analytical Solutions Division at Bio-techne

Dr. Chris Heger serves as the Director of Applications Science for Bio-Techne. He received his Ph.D. in Pharmacology from Cornell University and completed his post-doctoral training at the NCI. He joined Bio-Techne in 2012 and currently leads Applications Science group chartered with applications and content development, fostering collaborations, and providing custom analytical solutions. He’s a member of Bio-Techne’s Science and Technology Council and serves as technical expert for Bio-Techne Corporate Development.

SPEAKERS

Lisa Mutz
Lisa Mutz
Product Manager at PROGEN
Chris Heger
Chris Heger
Director of Applications Science, Analytical Solutions Division at Bio-techne